Research Article

Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus

Journal of General Virology 1997; 78(8):1923

Download PDF PubMed

Summary auto-generated

Researchers investigated superinfection resistance in macaques infected with attenuated simian immunodefiency virus (SIVmac). Three macaques previously infected with attenuated SIVmacC8 were challenged with blood from a macaque (29R) in which a virulent revertant virus had emerged through repair of a 12 bp deletion in the nef gene. The three vaccinated macaques successfully resisted superinfection with the revertant virus, while four naive control animals became persistently infected. Sequence analysis revealed that macaque 29R had accumulated multiple mutations following repair of the attenuating lesion, coinciding with clinical decline and development of AIDS-like pathology. Notably, nef-specific cytotoxic T lymphocyte (CTL) responses were detected in 29R before reversion but were lost after the repair event, suggesting possible escape from CTL-driven selection pressure. The findings demonstrate that superinfection resistance persists against in vivo-reverted virus, supporting the potential of attenuated SIV as a vaccine model. However, the results suggest that viral niche occupation rather than antibody-mediated immunity may be critical for protection, raising important questions about safe vaccine development.

Key findings

  • Macaques infected with attenuated SIVmacC8 successfully resisted superinfection with virulent revertant virus that arose in vivo through repair of a 12 bp nef deletion.
  • A virulent revertant virus emerged in one macaque (29R) despite superinfection resistance in other vaccinated animals, accumulating multiple mutations in nef that correlated with disease progression and AIDS pathology.
  • Loss of nef-specific CTL responses preceded virulence reversion, suggesting the virus may have escaped from CTL-driven immune pressure.
  • Passive transfer of serum and evidence against CTL depletion studies suggest humoral immunity is unlikely to be the primary mechanism of superinfection resistance.
  • The dominant mechanism of superinfection resistance may involve viral niche occupation by the resident attenuated virus rather than specific immune responses.

This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.

Abstract

Macaques infected with attenuated simian immunodeficiency virus (SIVmac) can resist superinfection challenge with virulent virus, showing the potential of live attenuated virus as an AIDS vaccine. Superinfection resistance does not, however, prevent the generation of virulent virus in vivo, suggesting that such virus may circumvent the resistance effect. Here, we show that three macaques already infected with the attenuated molecular clone SIVmacC8 were resistant to superinfection with virulent virus that arose in vivo following repair of a 12 bp attenuating lesion in the nef/3' LTR. In contrast, four naive animals became infected following inoculation with blood taken from the macaque in which virulent virus arose. Loss of nef-specific cytotoxic T lymphocyte (CTL) responses followed repair of the attenuating lesion within nef in the donor animal, suggesting the possibility of escape from CTL-driven selection pressure.